Cargando…

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia

The introduction of miR profiling of chronic lymphocytic leukemia (CLL) patients with different cytogenetic profiles and responses to therapy has allowed incorporation of important miR‐mRNA interactions into the understanding of disease biology. In this study, we performed miR expression analysis us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guinn, Daphne, Lehman, Amy, Fabian, Catherine, Yu, Lianbo, Maddocks, Kami, Andritsos, Leslie A., Jones, Jeffrey A., Flynn, Joseph M., Jaglowski, Samantha M., Woyach, Jennifer A., Byrd, John C., Johnson, Amy J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387133/ https://www.ncbi.nlm.nih.gov/pubmed/28299881 http://dx.doi.org/10.1002/cam4.996

Ejemplares similares

Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center
por: Stephens, Deborah M., et al.
Publicado: (2014)

miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.
por: Guinn, Daphne, et al.
Publicado: (2014)

Dinaciclib is a Novel Cyclin Dependent Kinase Inhibitor with Significant Clinical Activity in Relapsed and Refractory Chronic Lymphocytic Leukemia
por: Flynn, Joseph, et al.
Publicado: (2015)

Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia
por: Chen, Timothy L., et al.
Publicado: (2016)

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia
por: Heerema, Nyla A., et al.
Publicado: (2020)

Risk Factors for Tumor Lysis Syndrome in patients with Chronic Lymphocytic Leukemia Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol
por: Blum, Kristie A., et al.
Publicado: (2011)

Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia
por: Cohen, Jonathon B., et al.
Publicado: (2012)

Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemia
por: Muhowski, Elizabeth M., et al.
Publicado: (2022)

Update in the management of chronic lymphocytic leukemia
por: Maddocks, Kami J, et al.
Publicado: (2009)

Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors
por: Bond, David A, et al.
Publicado: (2020)

Management of relapsed/refractory Chronic Lymphocytic Leukemia
por: Woyach, Jennifer A.
Publicado: (2022)

Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease
por: Hertlein, Erin, et al.
Publicado: (2013)

The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model
por: Beckwith, Kyle A., et al.
Publicado: (2014)

HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia
por: Lai, Tzung-Huei, et al.
Publicado: (2022)

Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B cell cytotoxicity in chronic lymphocytic leukemia
por: Mani, Rajeswaran, et al.
Publicado: (2014)

What's new in the management of chronic lymphocytic leukemia? 2008 ASH Review (New York Medical College, January 31, 2009)
por: Maddocks, Kami J, et al.
Publicado: (2009)

A Phase I/II Study of Etanercept and Rituximab in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
por: Woyach, Jennifer A, et al.
Publicado: (2009)

Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer
por: Sun, Lin, et al.
Publicado: (2020)

Mitochondrial Priming of Chronic Lymphocytic Leukemia Patients Associates Bcl-x(L) Dependence with Alvocidib Response
por: Pierceall, William E., et al.
Publicado: (2014)

Optimizing extracellular vesicles’ isolation from chronic lymphocytic leukemia patient plasma and cell line supernatant
por: Elgamal, Sara, et al.
Publicado: (2021)

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
por: Walker, Janek S., et al.
Publicado: (2021)

E3 Ubiquitin ligase RNF126 regulates the progression of tongue cancer
por: Wang, Lina, et al.
Publicado: (2016)

Pericardial Involvement with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Rare Case of Constrictive Pericarditis
por: Ho, Natalie, et al.
Publicado: (2018)

Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia
por: Walker, Janek S., et al.
Publicado: (2021)

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma
por: Jaglowski, Samantha M., et al.
Publicado: (2014)

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes
por: Sherry, Barbara, et al.
Publicado: (2015)

Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
por: Hing, Zachary A., et al.
Publicado: (2023)

Hairy Cell Leukemia: Where Are We in 2023?
por: Mendez-Hernandez, Andres, et al.
Publicado: (2023)

Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant
por: Liu, Qiuying, et al.
Publicado: (2021)

Comparison of the mRNA expression profile of B‐cell receptor components in normal CD5‐high B‐lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70
por: Gladkikh, Aleena A., et al.
Publicado: (2017)

Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis
por: Guo, Ran, et al.
Publicado: (2020)

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy
por: Yano, Max, et al.
Publicado: (2022)

Gain of the short arm of chromosome 2 (2p gain) has a significant role in drug‐resistant chronic lymphocytic leukemia
por: Kostopoulou, Fotini, et al.
Publicado: (2019)

Residential proximity to petrol stations and risk of childhood leukemia
por: Malavolti, Marcella, et al.
Publicado: (2023)

B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
por: Woyach, Jennifer A., et al.
Publicado: (2023)

Incidence and survival of hematological cancers among adults ages ≥75 years
por: Krok‐Schoen, Jessica L., et al.
Publicado: (2018)

Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients
por: Chauzeix, Jasmine, et al.
Publicado: (2018)

Lipids and Their Effects in Chronic Lymphocytic Leukemia
por: Friedman, Daphne R.
Publicado: (2016)

A single center’s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation
por: Haverkos, Bradley M., et al.
Publicado: (2017)

National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population‐based data
por: Lenartova, Andrea, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_anijhps7ukq4d9akcg7v7h5ora